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httpIt is very difﬁcult to identify whether the use of the thermosensitive polymer LeGoo offers advantages over the
use of clamps or clampless techniques for infra-inguinal bypass. This issue of the journal provides much additional
information about the use of LeGoo. We have summarised all the available evidence. In a very heterogeneous
patient population, with heterogeneous graft type and location, the primary technical success rate remains high
at 90% [95%CI 83e99], the 3 months secondary graft patency is 71 [95%CI 58e84]% and limb salvage is 78%
[95%CI 68e89]%. These promising early results need to be followed by extended follow up of the patients and
standardised outcome reporting in the future.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The thermosensitive polymer LeGoo is being marketed for
clampless bypass on the basis that it prevents damage to
vulnerable arteries (particularly those which are calciﬁed)
and therefore to theoretically improve long-term patency
and minimise secondary interventions. This issue of the
journal contains the experience of 2 centres, one in
Switzerland and one in England in using LeGoo for the
temporary occlusion of infra-inguinal vessels during bypass
surgery and consolidates the previous French study report-
ing technical success only.1e3 To summarise these ﬁndings
and place them in perspective, we undertook a systematic
review of the literature and sought information from
unpublished studies in elsewhere in Europe (to overcome
any potential bias in favour of publishing successful studies).
Here the aims are to systematically and critically review
published and unpublished data for the use of LeGoo in
peripheral arterial reconstruction.
METHODS & RESULTS
A systematic review was conducted according to PRISMA
guidelines using a pre-deﬁned protocol with standard format
data extraction (Supplementary data). The published litera-
ture, including clinical trial databases, has been systemati-
cally searched up and until October 2012, which identiﬁed
only 4 eligible studies, contributing 83 patients.1e4 In addi-
tion we have attempted to identify unpublished patientof original articles: http://dx.doi.org/10.1016/j.ejvs.2012.10.002,
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://dx.doi.org/10.1016/j.ejvs.2012.10.021series elsewhere in Europe through advertisements at recent
vascular surgical meetings in Europe, including the European
Society of Vascular Surgery in Bologna, September 2012: this
identiﬁed 3 unpublished studies, albeit with limited numbers
(a total of 14 bypasses in 14 patients) and limited follow up
information. In total, we identiﬁed 105 separate bypasses
which used LeGoo in 100 limbs of 97 patients. Many of the
cases were technically challenging, often in patients with
diabetes or chronic kidney disease, usually for critical limb
ischaemia and redo procedures, and used saphenous vein,
arm veins and prosthetic materials for bypass conduits:
therefore the patient group and type of bypass are both very
heterogeneous. LeGoo was used for the distal anastomoses.
The technical success rate, reported in all studies,
continues to be very high 95/105 (90% [95%CI 83e99]),
although sometimes assisted success is reported (Fig. 1A).
However, nearly every study identiﬁed problems with plug
emboli in the ﬁrst one or two cases, which led one centre to
discontinue use of LeGoo. Plugs were readily removed by
embolectomy. Following the peri-operative period
secondary interventions to preserve graft patency was
necessary in about 10% of cases but these were not re-
ported consistently.
Across the separate studies, conﬁdence intervals have not
been reported and there have been no standardised
outcomes or criteria for vessel patency and only the largest
study4 reports patency and limb salvage rates to 12 months.
We focused on outcomes at 3 months; summary secondary
patency was 71% [95%CI 58e84], limb salvage 78% [95%CI
68e89] limbs (Fig. 1B) and survival 81% [95%CI 56e92]. No
study has follow up of 12 months or more on all patients.
DISCUSSION
The total published experience of using LeGoo to provide
temporary occlusion of infra-inguinal vessels is limited and
this issue of the journal provides the majority of world
experience and the total world experience of outcomes
beyond 30 days. Technical success rate is high, but higher in
published than unpublished studies. This is probably the
Figure 1. Summary data for studies using LeGoo (A) technical
success (%) and (B) 3 month limb salvage (%), with lines showing
95% conﬁdence intervals.
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become discouraged from further use. Centres encountered
residual plug emboli in the ﬁrst one or two cases, since
the recommended technique of plug solution by application
of cold saline to the exterior of the vessel does not appear
to be as effective as either intra-arterial or particularly
plug injection of cold saline. The volumes of LeGoo required
are usually small (less than a 0.5 ml LeGoo syringe) and
the mean occlusion time is in the range 13e15 min,
which usually provides adequate time to complete the
anastomosis.
The patency rates and limb salvage reported at 3 months
are similar to those of clampless bypasses of comparable
complexity, conducted without LeGoo occlusion but in the
future should be reported with associated conﬁdence
intervals.5 There is no proof that LeGoo provides better
outcomes than the use of occlusion balloons or other
techniques in either heavily calciﬁed or other diseased
infrainguinal arteries and mid and long-term results remain
conspicuously absent as is the use of standardised reporting
standards6. Better data, from a randomised trial, are avail-
able for the use of LeGoo in coronary artery bypass.7 LeGoo
also is being used for larger arteries e.g. femoral arteries:
this too would beneﬁt from formal evaluation.LeGoo remains a promising adjunct technique for
vascular surgeons but more comprehensive reporting, using
standardised criteria, of its use and complications, with
more than short term follow up is essential. Only in this way
can the advantages of LeGoo be exploited appropriately.
Therefore, we would be pleased to continue adding data to
an on-going systematic review.
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Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.ejvs.2012.10.021.REFERENCES
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